I am rather shocked at the lack of depth and sudden downfall. I am holding tight but not willing to top up unless I see some directors buy up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025